Neutral
●
GlobeNewsWire
●
4 months ago
Press release – No. 13 / 2026 New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity Clinically meaningful, double-digit weight loss demonstrated through week 42 Placebo-like tolerability observed and low rates of trea...